# Neonatal Erythropoietin in Asphyxiated Term Newborns

> **NCT00719407** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 24 (actual)

## Conditions studied

- Hypoxic-ischemic Encephalopathy

## Interventions

- **DRUG:** erythropoietin

## Key facts

- **NCT ID:** NCT00719407
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-09
- **Final completion:** 2012-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-11-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719407, "Neonatal Erythropoietin in Asphyxiated Term Newborns". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00719407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*